Search

Filter By:

Licensing & tax planning for emerging life sciences companies

Discover key licensing and tax planning strategies for emerging life sciences companies. Our professionals from BPM and Mayer Brown will cover R&D tax credits, transfer pricing, and international expansion to help you navigate complex challenges.

Learn More

Digital asset investments and transactions: Key strategic, IP, and tax considerations

Join BPM and Mayer Brown as they unpack how to capitalize on digital asset opportunities while managing the risks. This session will cover strategies for aligning digital innovation with business goals, safeguarding IP, and navigating global tax structuring to drive growth with confidence.

Learn More

FinTech’s tax advantages under new OBBBA 

The OBBBA introduces powerful tax benefits for FinTech companies, including enhanced interest deductions, GILTI and FDII changes, and BDC investment opportunities.

Learn More

How the OBBBA will reshape your international tax strategy 

The recently enacted “One Big Beautiful Bill Act” (OBBBA) has introduced sweeping changes to the U.S. international tax landscape.

Learn More

Navigating new challenges: How tariffs, taxes, and R&D regulations are reshaping Biotech 

Biotech companies face evolving tariffs, tax rules, and R&D regulations. Learn key impacts and strategies to stay competitive in a shifting landscape.

Learn More

Potential tax law changes in the new Trump Administration

The Tax Cuts and Jobs Act (“TCJA”) of 2017, signed into law by Donald Trump in his first term, brought …

Learn More

Section 174 R&D cost capitalization updates from the IRS

Notice 2023-63, Notice 2024-12 and Revenue Procedure 2024-9 Main takeaways Notice 2023-63 provides additional context and examples related to the …

Learn More

BPM International Tax Services European Tax Disclosure Requirements DAC 7 Reporting

On March 22, 2021, the European Council adopted the EU Directive 2021/514 (also known as “DAC 7”), extending the scope …

Learn More